This press release does not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which ...
Tempus AI, Inc. (NASDAQ: TEM) today announced results from a study evaluating an AI-enabled pre-screening panel for patients with advanced non-small cell lung cancer (NSCLC). The panel achieved ...
Rejoignez 100 millions de traders et d'investisseurs qui prennent leur avenir en main.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results